Predicting side-specific extraprostatic extension in prostate cancer using an 18F-DCFPyL PSMA-PET/CT-based nomogram.

Neeraja Tillu1, Ashutosh Maheshwari2, Kaushik Kolanukuduru2

  • 1Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA. neeraja.tillu@mountsinai.org.

Summary

Prostate cancer (PCa) extraprostatic extension (EPE) prediction is improved using 18F-DCFPyL prostate-specific membrane antigen (PSMA) PET/CT. This PSMA PET/CT model, combined with MRI and clinical data, offers better preoperative assessment than MRI alone.

Related Concept Videos